NCT04565977View on ClinicalTrials.gov

Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 10, 2021

Study Completion Date

June 10, 2021

Conditions
Hypercoagulable States
Interventions
OTHER

Observational

Retrospective chart review

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04565977 - Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States | Biotech Hunter | Biotech Hunter